Protirelin

Protirelin Overview

Protirelin is a synthetic tripeptide analogue that is chemically identical to endogenous human thyrotropin-releasing hormone (TRH). Chemically, it belongs to the oligopeptides class within the amino acids, peptides, and analogues subclass. Structurally, it consists of a three-amino-acid sequence: L-pyroglutamyl-L-histidyl-L-proline amide (pGlu-His-Pro-NH2​). The modified N-terminal pyroglutamyl ring and C-terminal proline amide group protect the peptide from rapid degradation by non-specific aminopeptidases.

In clinical endocrinology and neuroendocrinology, Protirelin serves as a diagnostic agent in the performative TRH stimulation test. It is utilized to evaluate the secretory reserve and functional integrity of the anterior pituitary gland, aiding in the differential diagnosis of thyroid and pituitary disorders, including secondary (pituitary) versus tertiary (hypothalamic) hypothyroidism, central hyperthyroidism, and hyperprolactinemia, as well as evaluating growth hormone dynamics in acromegaly. Formulated for intravenous injection, Protirelin has been marketed under trade names such as Relefact TRH and Thypinone.

What Is Protirelin and How Does It Work?

Protirelin is a small molecule tripeptide hormone that acts as a direct agonist at the human thyrotropin-releasing hormone receptor (TRH-R) on anterior pituitary cells.

Its primary physiological, biochemical, and endocrine mechanisms include:

• TRH Receptor Binding: Following intravenous bolus injection, Protirelin binds with high selectivity to G-protein-coupled TRH receptors expressed on the plasma membranes of thyrotroph and lactotroph cells within the anterior pituitary gland.
• Intracellular Phospholipase C Cascade: Receptor activation stimulates the Gq/11​ protein-coupled phospholipase C (PLC) signaling pathway, inducing membrane phosphatidylinositol 4,5-bisphosphate (PIP2​) cleavage into inositol 1,4,5-trisphosphate (IP3​) and diacylglycerol (DAG).
• Calcium Mobilization & Hormone Exocytosis: IP3​ triggers rapid calcium release from the endoplasmic reticulum into the cytosol. Elevated intracellular free calcium induces immediate exocytosis of stored pre-formed thyroid-stimulating hormone (TSH) from thyrotrophs and prolactin (PRL) from lactotrophs into systemic circulation.

Is Protirelin FDA Approved?

Yes, Protirelin was approved by the US FDA. It received its official FDA New Drug Application (NDA) approval in October 1976 under the brand name Thypinone (and later Thyrel TRH) as a diagnostic agent for evaluating pituitary and thyroid function. However, commercial manufacturing and distribution were voluntarily discontinued by December 2002, moving its current marketing status to discontinued/inactive in the United States.

What Is Protirelin Used For?

• Epicutaneous diagnostic evaluation (TRH stimulation test) of anterior pituitary reserve to assess TSH release capabilities.
• Differential diagnosis of central hypothyroidism, distinguishing secondary hypothyroidism (pituitary defect: blunted/absent TSH response) from tertiary hypothyroidism (hypothalamic defect: delayed or exaggerated TSH response).
• Diagnostic evaluation of suspected subclinical hyperthyroidism or thyroid hormone resistance syndromes.
• Assessment of prolactin reserve in suspected hypothalamic-pituitary axis lesions and paradoxical growth hormone secretion in acromegaly.

Before Taking Protirelin: Contraindications & Precautions

Do not perform diagnostic testing if you have a documented severe hypersensitivity to Protirelin or formulation excipients. Strictly contraindicated in patients with severe, unstable cardiovascular disease (e.g., recent myocardial infarction, unstable angina, uncontrolled hypertension), pre-existing severe bronchial asthma, or large pituitary macroadenomas with acute apoplexy risks. Defer testing during pregnancy unless urgent evaluation of maternal pituitary function is required.

Who Should Not Take Protirelin?

• Individuals with a documented severe hypersensitivity or systemic allergic reaction to Protirelin or formulation excipients.
• Patients with severe, unstable cardiovascular disease (e.g., recent myocardial infarction, unstable angina, uncontrolled hypertension), as rapid transient changes in blood pressure may occur.
• Patients with pre-existing severe bronchial asthma or obstructive airway disease, due to minor risks of transient bronchospasm.
• Patients with severe pituitary macroadenomas presenting with visual field deficits or acute pituitary apoplexy risk.

Protirelin, Pregnancy & Fertility

Systemic drug exposure occurs rapidly during diagnostic testing. Protirelin crosses the human placenta. While single diagnostic doses during pregnancy have not been formally shown to cause direct fetal malformations, diagnostic testing is generally deferred during pregnancy unless diagnostic urgency requires assessment of maternal pituitary function. It is unknown whether transient diagnostic administration poses risks during lactation.

Tell Your Doctor Before Taking Protirelin

Inform your endocrinologist or physician if you have a history of severe hypertension, coronary artery disease, seizures, bronchial asthma, or a known pituitary tumor. Disclose all prescription medications you take, particularly thyroid hormones, corticosteroids, levodopa, or dopamine agonists.

Protirelin Dosage & Administration

Administered strictly via the intravenous route by a qualified healthcare professional in a clinical facility. The standard adult diagnostic dosage for the TRH stimulation test is 200 mcg to 500 mcg (typically 500 mcg) given as a single rapid intravenous bolus; the pediatric dose is 7 mcg/kg of body weight (up to 500 mcg max). Sequential venous blood draws for serum TSH and prolactin levels are drawn at baseline ($t=0$), and then typically at 15, 30, 45, 60, and 120 minutes post-injection while the patient remains supine.

Standard Protirelin Dosing

• Intravenous Diagnostic TRH Test (Adults): The standard diagnostic dosage is 200 mcg to 500 mcg (typically 500 mcg) administered as a rapid single bolus injection intravenously.
• Pediatric Diagnostic Dose: 7 mcg/kg of body weight (up to a maximum total dose of 500 mcg) administered as a rapid intravenous bolus.

How Protirelin Is Administered

• Administered strictly via the intravenous route by a qualified medical professional in a clinical testing facility.
• Patient should remain seated or supine during administration and for at least 30 minutes post-injection.
• Venous blood samples for serum TSH baseline determination are drawn immediately prior to injection (t=0), followed by sequential post-injection blood draws at 15, 30, 45, 60, and 120 minutes.

Protirelin Clinical Efficacy & Research

Clinical literature establishes that the Protirelin (TRH) stimulation test provides precise, diagnostic discrimination in complex hypothalamic-pituitary-thyroid axis pathology. In healthy controls, Protirelin induces a clear TSH elevation (ΔTSH>6 μIU/mL). In patients with primary hyperthyroidism, baseline serum thyroid hormones (T3​,T4​) exert negative feedback at the pituitary, resulting in complete suppression of TSH response to Protirelin. Conversely, patients with hypothalamic tertiary hypothyroidism exhibit a delayed peak in serum TSH (at 60 to 120 minutes), whereas those with intrinsic pituitary damage show little to no TSH surge.

Protirelin Side Effects & Safety Profile

Common reactions occur within seconds of injection and resolve in 1 to 5 minutes, including transient facial flushing, a sensation of warmth, a sudden urge to urinate, metallic taste, lightheadedness, and transient blood pressure/heart rate fluctuations. Serious adverse risks include severe hypertensive urgency, acute hypotensive collapse, bronchospasm, seizures in patients with pre-existing seizure disorders, and pituitary apoplexy (hemorrhage into a pituitary macroadenoma). Holds no FDA Black Box Warning.

Common Protirelin Side Effects

• Transient flushing, sensation of warmth, or skin tingling immediately after bolus injection.
• Sudden urge to urinate or sensation of pelvic/abdominal warmth.
• Transient nausea, metallic taste, or mild lightheadedness.
• Mild, transient elevation or drop in blood pressure and transient heart rate changes.

Serious Protirelin Adverse Events

• Severe Transient Blood Pressure Spikes / Hypotension: Sudden hypertensive urgency or acute hypotensive collapse.
• Bronchospasm & Respiratory Distress: Sudden airway constriction in susceptible asthmatic patients.
• Seizures: Rare occurrence of convulsions in patients with pre-existing seizure disorders or central nervous system lesions.
• Pituitary Apoplexy: Hemorrhage or infarction into a pre-existing pituitary macroadenoma following acute glandular stimulation.

Managing Protirelin Side Effects

Most common side effects (flushing, nausea, urinary urge) are mild and resolve spontaneously within 1 to 5 minutes following injection. Keep the patient supine during testing. Monitor blood pressure and pulse prior to injection and every 15 minutes post-injection until stable.

Protirelin Drug Interactions & What to Avoid

Levothyroxine, liothyronine, high-dose systemic corticosteroids, somatostatin analogues, and dopamine agonists (e.g., bromocriptine, levodopa) blunt or abolish the pituitary TSH response to Protirelin; withhold thyroid replacement under medical supervision prior to testing if accurate baseline testing is desired. Fast from food for at least 4 to 8 hours prior to diagnostic testing to avoid dietary interference.

Protirelin Drug-Drug Interactions

• Thyroid Hormones (Levothyroxine, Liothyronine): High circulating levels of T4​ or T3​ blunts or abolishes the pituitary TSH response to Protirelin. Thyroid hormone replacement should be held prior to testing under medical direction if accurate baseline testing is desired.
• Corticosteroids & Somatostatin: High-dose systemic corticosteroids or somatostatin analogues blunt the TSH response to Protirelin.
• Dopamine Agonists (Levodopa, Bromocriptine): Suppress TSH response to Protirelin.
• Estrogens & Anti-Psychotics (Dopamine Antagonists): May enhance or blunts baseline prolactin or TSH release.

Protirelin, Food & Alcohol

Patients should fast from food for at least 4 to 8 hours prior to diagnostic Protirelin testing to eliminate dietary interference with baseline TSH and prolactin secretion.

Protirelin: Missed Dose, Overdose & Storage

Because Protirelin is a single-dose diagnostic agent, missed dose rules do not apply; interrupted testing sessions must be rescheduled. Acute overdose (>1000 mcg) exaggerates autonomic symptoms (intense nausea, severe flushing, sweating, extreme blood pressure spikes), requiring supportive cardiovascular care while serum peptidases rapidly clear the peptide (plasma half-life is ~5 minutes). Store ampoules/vials at controlled room temperature (15°C–30°C) or under refrigeration (2°C–8°C) protected from light.

Missed Dose of Protirelin

Because Protirelin is administered as a single, time-critical diagnostic intravenous injection during a scheduled medical test, standard missed dose rules do not apply. If a testing session is interrupted, it must be rescheduled.

Protirelin Overdose & Emergency

Accidental acute administration of high doses (e.g., >1000 mcg) causes exaggerated transient autonomic symptoms, including intense nausea, severe facial flushing, profound sweating, severe hypertension, or sudden hypotension. In cases of overdose, keep the patient supine and provide supportive cardiovascular care; symptoms resolve rapidly as the peptide is cleared by serum peptidases (half-life approximately 5 minutes).

How to Store Protirelin

Store diagnostic ampoules or vials at controlled room temperature between 15°C and 30°C (59°F to 86°F), or under refrigeration (2°C to 8°C) as specified by the manufacturer. Protect from light. Do not use if solution is discolored or contains particulate matter. Keep strictly out of reach of children.

Protirelin Patient Management & Monitoring

Obtain baseline serum TSH, free T4, free T3, serum prolactin, blood pressure, and heart rate prior to initiating the test. Keep the patient seated or supine throughout administration and for at least 30 minutes post-injection. Continuously monitor blood pressure and pulse immediately before the bolus and at 15-minute intervals throughout the 60-to-120-minute diagnostic window.

Tests Before Starting Protirelin

• Baseline serum TSH, free T4​, free T3​, and serum prolactin levels.
• Baseline blood pressure, heart rate, and pregnancy screen if clinically indicated.

Monitoring During Protirelin Treatment

Continuous monitoring of blood pressure and pulse immediately before injection and at 15-minute intervals throughout the 60-to-120-minute diagnostic testing window.

Protirelin Do’s and Don’ts

• Do remain lying down or seated during the diagnostic test.
• Do inform the clinician immediately if experiencing severe dizziness, chest pain, or trouble breathing during injection.
• Do not stand up quickly after injection to avoid orthostatic lightheadedness.
• Do not take thyroid medications on the morning of testing unless instructed by your doctor.

Frequently Asked Questions

References

• DrugBank Database – Protirelin Clinical and Pharmacological Profile (DB09421)
• Classyfire Database – Oligopeptides Chemical Taxonomy Profile

Legal Disclaimer

The detailed medical and chemical information provided on this specific web page is intended strictly for educational and informational purposes regarding complex pharmacological mechanisms. It absolutely does not constitute professional medical advice, medical diagnosis, or specific treatment recommendations. Always consult a licensed healthcare provider before making any personal decisions regarding complex medical conditions, medication adjustments, or dietary changes.